18-10763009-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001378183.1(PIEZO2):​c.3036A>G​(p.Thr1012Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.803 in 1,537,182 control chromosomes in the GnomAD database, including 496,371 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.83 ( 52906 hom., cov: 35)
Exomes 𝑓: 0.80 ( 443465 hom. )

Consequence

PIEZO2
NM_001378183.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.382

Publications

19 publications found
Variant links:
Genes affected
PIEZO2 (HGNC:26270): (piezo type mechanosensitive ion channel component 2) The protein encoded by this gene contains more than thirty transmembrane domains and likely functions as part of mechanically-activated (MA) cation channels. These channels serve to connect mechanical forces to biological signals. The encoded protein quickly adapts MA currents in somatosensory neurons. Defects in this gene are a cause of type 5 distal arthrogryposis. Several alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Feb 2014]
PIEZO2 Gene-Disease associations (from GenCC):
  • Gordon syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • arthrogryposis, distal, with impaired proprioception and touch
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics
  • arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • connective tissue disorder
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • Marden-Walker syndrome
    Inheritance: AR, AD Classification: MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 18-10763009-T-C is Benign according to our data. Variant chr18-10763009-T-C is described in ClinVar as Benign. ClinVar VariationId is 261504.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.382 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.925 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIEZO2NM_001378183.1 linkc.3036A>G p.Thr1012Thr synonymous_variant Exon 22 of 56 ENST00000674853.1 NP_001365112.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIEZO2ENST00000674853.1 linkc.3036A>G p.Thr1012Thr synonymous_variant Exon 22 of 56 NM_001378183.1 ENSP00000501957.1 A0A2H4UKA7

Frequencies

GnomAD3 genomes
AF:
0.830
AC:
126324
AN:
152176
Hom.:
52852
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.933
Gnomad AMI
AF:
0.710
Gnomad AMR
AF:
0.758
Gnomad ASJ
AF:
0.846
Gnomad EAS
AF:
0.913
Gnomad SAS
AF:
0.764
Gnomad FIN
AF:
0.789
Gnomad MID
AF:
0.854
Gnomad NFE
AF:
0.789
Gnomad OTH
AF:
0.819
GnomAD2 exomes
AF:
0.795
AC:
114981
AN:
144596
AF XY:
0.794
show subpopulations
Gnomad AFR exome
AF:
0.934
Gnomad AMR exome
AF:
0.721
Gnomad ASJ exome
AF:
0.840
Gnomad EAS exome
AF:
0.914
Gnomad FIN exome
AF:
0.775
Gnomad NFE exome
AF:
0.795
Gnomad OTH exome
AF:
0.806
GnomAD4 exome
AF:
0.799
AC:
1107155
AN:
1384888
Hom.:
443465
Cov.:
59
AF XY:
0.798
AC XY:
545284
AN XY:
683362
show subpopulations
African (AFR)
AF:
0.935
AC:
29541
AN:
31592
American (AMR)
AF:
0.727
AC:
25962
AN:
35700
Ashkenazi Jewish (ASJ)
AF:
0.838
AC:
21096
AN:
25180
East Asian (EAS)
AF:
0.902
AC:
32242
AN:
35734
South Asian (SAS)
AF:
0.765
AC:
60601
AN:
79226
European-Finnish (FIN)
AF:
0.776
AC:
27156
AN:
35014
Middle Eastern (MID)
AF:
0.832
AC:
4737
AN:
5696
European-Non Finnish (NFE)
AF:
0.796
AC:
858758
AN:
1078822
Other (OTH)
AF:
0.812
AC:
47062
AN:
57924
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
12534
25068
37602
50136
62670
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20434
40868
61302
81736
102170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.830
AC:
126438
AN:
152294
Hom.:
52906
Cov.:
35
AF XY:
0.829
AC XY:
61752
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.933
AC:
38787
AN:
41580
American (AMR)
AF:
0.758
AC:
11596
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.846
AC:
2939
AN:
3472
East Asian (EAS)
AF:
0.913
AC:
4733
AN:
5182
South Asian (SAS)
AF:
0.764
AC:
3694
AN:
4832
European-Finnish (FIN)
AF:
0.789
AC:
8349
AN:
10584
Middle Eastern (MID)
AF:
0.857
AC:
252
AN:
294
European-Non Finnish (NFE)
AF:
0.789
AC:
53703
AN:
68028
Other (OTH)
AF:
0.822
AC:
1739
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1095
2191
3286
4382
5477
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
884
1768
2652
3536
4420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.796
Hom.:
15506
Bravo
AF:
0.835
Asia WGS
AF:
0.873
AC:
3038
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Gordon syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Marden-Walker syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Arthrogryposis, distal, with impaired proprioception and touch Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.36
DANN
Benign
0.36
PhyloP100
-0.38
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7227167; hg19: chr18-10763007; COSMIC: COSV108125172; COSMIC: COSV108125172; API